Loading clinical trials...
Loading clinical trials...
Previous studies found that some NMDA-enhancing agents were able to improve cognitive function of patients with early-phase dementia. In addition, several drugs with antioxidant properties have been t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chang Gung Memorial Hospital
NCT07571161 · Alzheimer Disease
NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT06937229 · Alzheimer Disease, Agitation
Chang Gung Memorial Hospital
Kaohsiung City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions